SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001062993-15-000736
Filing Date
2015-02-13
Accepted
2015-02-13 10:09:11
Documents
6
Period of Report
2015-03-26
Effectiveness Date
2015-02-13

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A def14a.htm DEF 14A 152545
2 EXHIBIT A exhibita.htm EX-99.1 539
3 EXHIBIT B exhibitb.htm EX-99.2 1932
4 GRAPHIC exhibitax1x1.jpg GRAPHIC 104738
5 GRAPHIC exhibitbx1x1.jpg GRAPHIC 91839
6 GRAPHIC anavexlogo.jpg GRAPHIC 4139
  Complete submission text file 0001062993-15-000736.txt   433177
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-51652 | Film No.: 15609756
SIC: 8731 Services-Commercial Physical & Biological Research